143 related articles for article (PubMed ID: 38163975)
1. [Impact of Folic Acid on the Resistance of Non-small Cell Lung Cancer Cells
to Osimertinib by Regulating Methylation of DUSP1].
He W; Liu L
Zhongguo Fei Ai Za Zhi; 2024 Jan; 26(12):881-888. PubMed ID: 38163975
[TBL] [Abstract][Full Text] [Related]
2. YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer.
Ning Y; Zheng H; Yang Y; Zang H; Wang W; Zhan Y; Wang H; Luo J; Wen Q; Peng J; Xiang J; Fan S
Int J Biol Sci; 2023; 19(8):2458-2474. PubMed ID: 37215986
[TBL] [Abstract][Full Text] [Related]
3. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.
Gil-Araujo B; Toledo Lobo MV; Gutiérrez-Salmerón M; Gutiérrez-Pitalúa J; Ropero S; Angulo JC; Chiloeches A; Lasa M
Mol Oncol; 2014 Feb; 8(1):27-38. PubMed ID: 24080497
[TBL] [Abstract][Full Text] [Related]
4. DUSP1 Promotes Osimertinib Drug-Tolerant Persistence by Inhibiting MAPK/ERK Signaling in Non-small Cell Lung Cancer.
He W; Liu P; Lei Q; Xu J; Liu L
Mol Biotechnol; 2024 Mar; ():. PubMed ID: 38551790
[TBL] [Abstract][Full Text] [Related]
5. DUSP1 expression induced by HDAC1 inhibition mediates gefitinib sensitivity in non-small cell lung cancers.
Lin YC; Lin YC; Shih JY; Huang WJ; Chao SW; Chang YL; Chen CC
Clin Cancer Res; 2015 Jan; 21(2):428-38. PubMed ID: 25593344
[TBL] [Abstract][Full Text] [Related]
6. CDKN2B antisense RNA 1 suppresses tumor growth in human colorectal cancer by targeting MAPK inactivator dual-specificity phosphatase 1.
Pan J; Lin M; Xu Z; Xu M; Zhang J; Weng Z; Lin B; Lin X
Carcinogenesis; 2021 Nov; 42(11):1399-1409. PubMed ID: 34436551
[TBL] [Abstract][Full Text] [Related]
7. DUSP1 is a novel target for enhancing pancreatic cancer cell sensitivity to gemcitabine.
Liu F; Gore AJ; Wilson JL; Korc M
PLoS One; 2014; 9(1):e84982. PubMed ID: 24409315
[TBL] [Abstract][Full Text] [Related]
8. USP49 inhibits ischemia-reperfusion-induced cell viability suppression and apoptosis in human AC16 cardiomyocytes through DUSP1-JNK1/2 signaling.
Zhang W; Zhang Y; Zhang H; Zhao Q; Liu Z; Xu Y
J Cell Physiol; 2019 May; 234(5):6529-6538. PubMed ID: 30246457
[TBL] [Abstract][Full Text] [Related]
9. Aloe-emodin targets multiple signaling pathways by blocking ubiquitin-mediated degradation of DUSP1 in nasopharyngeal carcinoma cells.
Chen S; Guan X; Xie L; Liu C; Li C; He M; Hu J; Fan H; Li Q; Xie L; Yang M; Zhang X; Xiao S; Tang J
Phytother Res; 2023 Jul; 37(7):2979-2994. PubMed ID: 36866539
[TBL] [Abstract][Full Text] [Related]
10. Caspase Recruitment Domain Containing Protein 9 Suppresses Non-Small Cell Lung Cancer Proliferation and Invasion via Inhibiting MAPK/p38 Pathway.
Pan L; Tan Y; Wang B; Qiu W; Yin Y; Ge H; Zhu H
Cancer Res Treat; 2020 Jul; 52(3):867-885. PubMed ID: 32164050
[TBL] [Abstract][Full Text] [Related]
11. [The role and mechanism of 2-deoxyglucose in reversing osimertinib-acquired resistance of non-small cell lung cancer cell line].
Hao S; Lu CH; Lin CC; Chen HY; Li L; Wang YB; Feng MX; He Y
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Mar; 42(3):198-205. PubMed ID: 30845397
[No Abstract] [Full Text] [Related]
12. Xiaoai Jiedu Recipe Inhibits Proliferation and Metastasis of Non-Small Cell Lung Cancer Cells by Blocking the P38 Mitogen-Activated Protein Kinase (MAPK) Pathway.
Wang Y; Xu C; Xu B; Li L; Li W; Wang W; Wu M
Med Sci Monit; 2019 Oct; 25():7538-7546. PubMed ID: 31590176
[TBL] [Abstract][Full Text] [Related]
13. ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition.
Liu K; Chen X; Wu L; Chen S; Fang N; Cai L; Jia J
BMC Pulm Med; 2021 May; 21(1):163. PubMed ID: 33992097
[TBL] [Abstract][Full Text] [Related]
14. [Role and mechanism of nonreceptor tyrosine kinase Tec in endotoxin/lipopolysaccharide-induced interleukin-8 production in human alveolar epithelial cells A549].
Wang Y; Hu Y; Wang F; Liu S; Wang YJ; Chen XL
Zhonghua Shao Shang Za Zhi; 2019 Aug; 35(8):580-586. PubMed ID: 31474037
[No Abstract] [Full Text] [Related]
15. Mitogen-Dependent Regulation of DUSP1 Governs ERK and p38 Signaling During Early 3T3-L1 Adipocyte Differentiation.
Ferguson BS; Nam H; Stephens JM; Morrison RF
J Cell Physiol; 2016 Jul; 231(7):1562-74. PubMed ID: 26566083
[TBL] [Abstract][Full Text] [Related]
16. DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer.
Teng F; Xu Z; Chen J; Zheng G; Zheng G; Lv H; Wang Y; Wang L; Cheng X
Oncol Rep; 2018 Sep; 40(3):1203-1222. PubMed ID: 29956792
[TBL] [Abstract][Full Text] [Related]
17. High Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Expression Promotes Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer via ERK/Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway.
Liu C; Li H; Jia J; Ruan X; Liu Y; Zhang X
Med Sci Monit; 2019 Jul; 25():5143-5149. PubMed ID: 31293277
[TBL] [Abstract][Full Text] [Related]
18. Unrestrained p38 MAPK activation in Dusp1/4 double-null mice induces cardiomyopathy.
Auger-Messier M; Accornero F; Goonasekera SA; Bueno OF; Lorenz JN; van Berlo JH; Willette RN; Molkentin JD
Circ Res; 2013 Jan; 112(1):48-56. PubMed ID: 22993413
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA SDPR-AS affects the development of non-small cell lung cancer by regulating SDPR through p38 MAPK/ERK signals.
Zhu J; Wang L; Liao R
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3172-3179. PubMed ID: 31352804
[TBL] [Abstract][Full Text] [Related]
20. DUSP1 Signaling Pathway Regulates Cytarabine Sensitivity in Acute Myeloid Leukemia.
Sun H; Ren Y; Zhou X; Chen Q; Liu Y; Zhu C; Ruan Y; Ruan H; Tong H; Ying S; Lin P
Technol Cancer Res Treat; 2023; 22():15330338231207765. PubMed ID: 37872685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
